Search Thermo Fisher Scientific
Having difficulties with your experiment?
We are dedicated to your success. Get back on track. View our expert recommendations for commonly encountered problem scenarios.
View the relevant questions below:
Beginning your experiment?
Visit our
Here are possible causes and solutions:
Cause | Solution |
Incorrect antibiotic used to select for transformants | Select for transformants on LB agar plates containing 100 μg/mL ampicillin. |
LR recombination reaction not treated with proteinase K | Treat reaction with proteinase K before transformation. |
Too much entry clone DNA used in the LR reaction | Use 50–150 ng of the entry clone in the LR reaction. |
Inappropriate ratio of entry clone:DEST vector used in the LR reaction | Aim for a 1:1 molar ratio of entry clone:DEST vector. |
LR recombination of >5 kb insert only incubated for 1 hr | For inserts larger than 5 kb, we recommend to incubate the LR reaction overnight. Note: This overnight incubation will also boost colony count for smaller inserts. |
Adenoviral Destination vector DNA was sheared | Use care when handling the adenoviral Destination vector. Do not perform excessive manipulations (e.g.,vortexing or pipetting the solution vigorously) that may shear the DNA. |
Didn’t use the suggested amount of LR Clonase® II enzyme mix or LR Clonase® II enzyme mix was inactive | -Make sure to store the LR Clonase® II enzyme mix at –20°C. |
Not enough LR reaction transformed | Transform 2–3 μL of the LR reaction into the appropriate competent E. coli strain. Use E. coli cells with a transformation efficiency >1 x 108 cfu/μg. |
Not enough transformation mixture plated | Increase the amount of E. coli plated. |
Here are possible causes and solutions:
Cause | Solution |
LR reaction transformed into an E. coli strain containing the F′ episome and the ccdA gene | Use an E. coli strain that does not contain the |
Deletions (full or partial) of the ccdB gene from adenoviral Destination vector | The adenoviral Destination vectors are provided in solution and are ready to use in an LR reaction. However, if you wish to propagate them, we recommend using One Shot® ccdB Survival™ 2 T1R Chemically Competent Cells (Cat. No. A10460). |
Here are possible causes and solutions:
Cause | Solution |
Low transfection efficiency: | -Use care when handling the adenoviral Destination vector. Do not perform excessive manipulations (e.g.,vortexing or pipetting the solution vigorously) that may shear the DNA. |
Viral supernatant too dilute | Concentrate virus using CsCl purification or any method of choice. |
Viral supernatant frozen and thawed multiple times | Do notfreeze/thaw viral supernatant more than 10 times. |
Gene of interest is large | Viral titers generally decrease as the size of the insert increases; inserts larger than 6 kb (for pAd/CMV/V5-DEST™) and 7.5 kb (for pAd/PL-DEST™) are not recommended. |
Gene of interest is toxic to cells | Generation of constructs containing activated oncogenes or potentially harmful genes is not recommended. |
Here are possible causes and solutions:
Cause | Solution |
Viral stocks stored incorrectly | Aliquot and store stocks at –80°C. Do not freeze/thaw more than 10 times. |
Incorrect titering of cell line used | Use the 293A cell line or any cell line with the characteristics discussed on page 23 of the manual. |
Agarose overlay incorrectly prepared | Make sure that the agarose is not too hot before addition to the cells; hot agarose will kill the cells. |
Viral stock with very low titer or very high titer | Titer adenovirus using a wider range of 10-fold serial dilutions (e.g.,10-2 to 10-8). |
This could be due to insufficient dilution of the viral supernatant. We recommend tittering the adenovirus stock using 10-fold serial dilutions ranging from 10-4 to 10-9.
Here are possible causes and solutions:
Cause | Solution |
Viral stocks stored incorrectly | Aliquot and store stocks at –80°C. Do not freeze/thaw more than 10 times. |
Gene of interest contains a Pac I site | Perform mutagenesis to change or remove the PacI site. |
Here are possible causes and solutions:
Cause | Solution |
Poor transduction efficiency: |
-Make sure that your cells are healthy before transduction. |
MOI too low | Transduce your adenoviral construct into cells using a higher MOI. |
Low viral titer | Amplify the adenoviral stock using the procedure on page 20 of the manual. |
Adenoviral stock contaminated with RCA (replication-competent adenovirus) | -Screen for RCA contamination. |
Cells harvested too soon after transduction | Do not harvest cells until at least 24 hours after transduction. |
Cells harvested too long after transduction | For actively dividing cells, assay for maximal levels of recombinant protein expression within 5 days of transduction. |
Gene of interest is toxic to cells | Generation of constructs containing activated oncogenes or potentially harmful genes is not recommended. |
Here are possible causes and solutions:
Cause | Solution |
Too much crude viral stock used | -Reduce the amount of crude viral stock used for transduction ordilute the crude viral stock. |
Wild-type RCA (replication-competent adenovirus) contamination | Screen for RCA contamination. Plaque purify to isolate recombinant adenovirus or prepare a new adenoviral stock. |
Gene of interest is toxic to cells | Generation of constructs containing activated oncogenes or potentially harmful genes is not recommended. |
For Research Use Only. Not for use in diagnostic procedures.